10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Author(s):
Bone, H.G.; Wagman, R.B.; Brandi, M.L.; Brown, J.P.; Chapurlat, R.; Cummings, S.R.; Czerwinski, E.; Fahrleitner-Pammer, A.; Kendler, D.L.; Lippuner, K.; Reginster, J.Y.; Roux, C.; Malouf, J.; Bradley, M.N.; Daizadeh, N.S.; Wang, A.; Dakin, P.; Pannacciulli, N.; Dempster, D.W.; Papapoulos, S.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-07-31
Language
English
Is part of
Lancet Diabetes and Endocrinology (2017), Vol. 5, no. 7, p. 513-523
hdl
1887/94860
doi
10.1016/S2213-8587(17)30138-9